Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Apr 1;83(4):381–389. doi: 10.1097/QAI.0000000000002265

Table 4:

Results of linear regression models predicting cycle threshold (Ct) value from the HIV diagnostic total nucleic acid PCR test

Univariate
Each covariate on their own predicting Ct
In whole population (N=316)
Multivariable
All covariates shown entered simultaneously into a model predicting Ct
In those VL <50 copies/mL at time of test (N=288)
Multivariable
All covariates shown entered simultaneously into a model predicting Ct
In ESRU only and VL <50 copies/mL at time of test (N=211)
Parameter estimate Standard error p-value Parameter estimate Standard error p-value Parameter estimate Standard error p-value
Age at ART start (months) −0.106 0.018 <0.0001 −0.115 0.018 <0.0001 −0.104 0.018 <0.0001
VL sustained <400 copies/mL during CHANGES (Yes vs. No) 1.804 0.214 <0.0001 1.572 0.227 <0.0001 1.371 0.241 <0.0001
Ever treated with EFV (Yes vs. No) 0.633 0.235 0.007 0.563 0.238 0.019 0.576 0.294 0.051
CD4+ T-cell count (cells/mm3) at PCR test (divided by 100) −0.029 0.037 0.426 −0.104 0.038 0.006 −0.098 0.038 0.010
Site (ESRU vs. PHRU) 0.403 0.265 0.130 0.504 0.264 0.057 - - -
VL <50 copies/mL at test 2.345 0.387 <0.0001 - - - - - -